OSE Immunotherapeutics has a total of 739 patents globally, out of which 301 have been granted. Of these 739 patents, more than 87% patents are active. The Europe (EPO) is where OSE Immunotherapeutics has filed the maximum number of patents, followed by United States of America and Japan. Parallelly, Europe (EPO) seems to be the main focused R&D centre and France is the origin country of OSE Immunotherapeutics.
OSE Immunotherapeutics was founded in 2012 and is a French clinical-stage biotechnology company focused on developing immunotherapies for cancer and immune-inflammatory diseases. The company’s business model is based on advancing first-in-class drug candidates through its proprietary research platforms and partnering selected programs with major pharmaceutical companies. Its pipeline includes immuno-oncology and immuno-inflammation therapies, such as cancer vaccines and immune-regulation treatments.
Do read about some of the most popular patents of OSE Immunotherapeutics which have been covered by us in this article and also you can find OSE Immunotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over OSE Immunotherapeutics patent portfolio.
How many patents does OSE Immunotherapeutics have?
OSE Immunotherapeutics has a total of 739 patents globally. These patents belong to 130 unique patent families. Out of 739 patents, 645 patents are active.
How Many Patents did OSE Immunotherapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | OSE Immunotherapeutics Applications Filed | OSE Immunotherapeutics Patents Granted |
| 2026 | 4 | 24 |
| 2025 | 18 | 42 |
| 2024 | 39 | 40 |
| 2023 | 48 | 32 |
| 2022 | 86 | 45 |
| 2021 | 36 | 53 |
| 2020 | 46 | 24 |
| 2019 | 106 | 19 |
| 2018 | 66 | 7 |
| 2017 | 134 | 2 |
How many OSE Immunotherapeutics patents are Alive/Dead?
Worldwide Patents
How Many Patents did OSE Immunotherapeutics File in Different Countries?
Countries in which OSE Immunotherapeutics Filed Patents
| Country | Patents |
| Europe (EPO) | 65 |
| United States Of America | 64 |
| Japan | 55 |
| China | 39 |
| Canada | 33 |
| Hong Kong (S.A.R.) | 31 |
| South Korea | 27 |
| Australia | 26 |
| Israel | 26 |
| Brazil | 19 |
| Spain | 19 |
| India | 16 |
| Denmark | 15 |
| Republic of Moldova | 15 |
| Mexico | 14 |
| Hungary | 13 |
| Poland | 13 |
| South Africa | 13 |
| Croatia | 9 |
| Philippines | 9 |
| Taiwan | 9 |
| New Zealand | 8 |
| Portugal | 8 |
| Serbia | 8 |
| Singapore | 8 |
| Tunisia | 8 |
| Viet Nam | 8 |
| Africa | 7 |
| Bulgaria | 7 |
| Morocco | 7 |
| Slovenia | 7 |
| Colombia | 6 |
| Costa Rica | 6 |
| Eurasia | 6 |
| Malaysia | 6 |
| Turkey | 6 |
| Argentina | 5 |
| Chile | 5 |
| Saudi Arabia | 5 |
| Ireland | 3 |
| Lithuania | 3 |
| Ukraine | 3 |
| El Salvador | 2 |
| Indonesia | 2 |
| Latvia | 2 |
| Romania | 2 |
| Russia | 2 |
| Finland | 1 |
| France | 1 |
| Macao | 1 |
| Uruguay | 1 |
Where are Research Centres of OSE Immunotherapeutics Patents Located?
10 Best OSE Immunotherapeutics Patents
WO2016063233A1 is the most popular patent in the OSE Immunotherapeutics portfolio. It has received 67 citations so far from companies like Kymab Limited. and Alexo Therapeutics Inc.
Below is the list of 10 most cited patents of OSE Immunotherapeutics
| Publication Number | Citation Count |
| WO2016063233A1 | 67 |
| WO2019175218A1 | 53 |
| WO2017068164A1 | 52 |
| WO2015189302A1 | 45 |
| WO2013056984A1 | 31 |
| WO2018104483A1 | 29 |
| US20170247464A1 | 18 |
| WO2018149938A1 | 18 |
| US8785604B2 | 16 |
| WO2020127369A1 | 16 |
What Percentage of OSE Immunotherapeutics US Patent Applications were Granted?
OSE Immunotherapeutics has filed 61 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 25 have been granted leading to a grant rate of 71.43 %.
Below are the key stats of Apple patent prosecution at the USPTO.
Which Law Firms are managing US Patents for OSE Immunotherapeutics?
| Law Firm | Total Applications | Success Rate |
| Thompson Coburn Llp | 21 | 64.29% |
| Saliwanchik Lloyd & Eisenschenk | 12 | 100.00% |
| Morgan Lewis & Bockius Llp | 9 | 66.67% |
| C O Vp Ip Legal | 5 | 100.00% |
| Arrigo Lee Guttman & Mouta Bellum Llp | 4 | 50.00% |
| Christopher Casieri | 4 | 0.00% |
| Cozen O Connor Boulder | 3 | 100.00% |
| Baker Botts LLP | 1 | 0.00% |
| Mcneill Pllc | 1 | 0.00% |
| Nixon & Vanderhye Pc | 1 | 100.00% |
What are OSE Immunotherapeutics key innovation segments?
What Technologies are Covered by OSE Immunotherapeutics?
The chart below distributes patents filed by OSE Immunotherapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where OSE Immunotherapeutics thinks it’s important to protect particular technological inventions.
R&D Focus: How has OSE Immunotherapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by OSE Immunotherapeutics?
